A new organisation calling itself ‘Fairness in Fees’ is preparing to challenge what it says is a price-fixing practice followed by lawyers in Cyprus.
The London-based group has commissioned competition law expert Robert O’Donoghue, of Brick Court Chambers who argues that the Cyprus Bar Association’s so-called minimum fee regulations – a set of rules mandating the minimum lawyers can charge for out-of-court cases – are in clear breach of the price-fixing and cartel provisions of Article 101 of the European Treaty and therefore of European law.
“The minimum fee regulations set out formulae for calculating lawyers’ fees irrespective of the time spent or the complexity of the matter,” said Fairness in Fees founder George Lambis. “This is believed to be unique within the EU.”
Under the CBA’s regulations, a straight-forward out-of-court execution of a will in which property of €1 million is to be distributed among the beneficiaries would incur €56,000 in legal fees.
Fairness in Fees plan to submit a formal complaint to the European Competition Commission, whose decision will take a few months.
Full content: Cyprus Property News
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan